SV: Paldean Fates Luxray 137/91: PSA 9 vs PSA 10
On SV: Paldean Fates Luxray 137/91, PSA 10 sells for 9x a PSA 9, a $200 delta, which is an unusually wide gem-mint premium. Based on the last tracked PSA 10 sale of $225.00 on May 1, 2026, the crack-and-resub math favors the resub: expected value is positive even at a conservative 15% upgrade probability.
PSA 10
$225.00
Last sale $225.00 on
PSA 9
$25.00
Last sale $25.00 on
PSA 8
$12.50
Last sale $12.50 on
The Spread
The PSA 9 to PSA 10 spread on Luxray 137/91 (SV: Paldean Fates).
$200
Dollar gap, PSA 9 to PSA 10
9x
PSA 10 sells for 9x a PSA 9
Three-Outcome EV Calculator
15%
70%
15%
Defaults are conservative starting points. Adjust based on the specific slab. A borderline 9 with strong centering plays differently than a 9 with edge wear.
PSA 10 outcome (sale price minus resub minus acquisition)
$0
PSA 9 outcome (regrade, no upgrade)
$0
PSA 8 outcome (downgrade, slower sell, tied capital)
$0
Expected Value
$0
Math favors holding the 9
Where this card lands in the broader SV: Paldean Fates picture: a modern-era card carrying a $200 gap between PSA 9 and PSA 10, a 9x multiple on the PSA 9 price.
Other SV: Paldean Fates Heavy Hitters
Track every grade tier. Spot every gap.
Real PSA prices across every grade tier. Free during beta.
Get Free Beta AccessFounding Member Cohort · Limited to the First 100 Members.